Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
Acta Paediatr. 2011 Mar;100(3):364-9. doi: 10.1111/j.1651-2227.2010.02074.x. Epub 2010 Nov 23.
This study was undertaken to evaluate the effects of repeated courses of antenatal corticosteroids (ACS) on foetal growth.
We studied 94 infants exposed to 2-9 courses of ACS. Mean gestational age (GA) at first exposure was 29 and at birth 34 weeks. Exposure data were retrieved from case record files. Information on potential confounders was collected from the Swedish Medical Birth Registry. Standard deviation scores (SDS) for birthweight (BW), birthlength (BL) and head circumference (HC) were calculated and considered as outcomes.
GA at start of ACS did not affect outcome. BW-SDS, BL-SDS and HC-SDS were -0.21, -0.19 and +0.25 in infants exposed to two courses, compared to -1.01, -1.04 and -0.23 in infants exposed to ≥ 4 courses of ACS (p = 0.04-0.07). In multiple regression analyses, ≥ 4 courses were associated with lower BW-SDS, BL-SDS and HC-SDS (p = 0.007-0.04) compared to SDS after 2-3 courses. The effects from ≥ 4 courses on BW and BL were comparable to reduction in birth size seen in twins and on HC to that observed after maternal smoking.
Multiple courses of ACS are associated with a dose-dependent decline in foetal growth, which may affect later development and health.
本研究旨在评估重复产前皮质类固醇(ACS)疗程对胎儿生长的影响。
我们研究了 94 名暴露于 2-9 个 ACS 疗程的婴儿。首次暴露的平均孕龄(GA)为 29 周,出生时为 34 周。暴露数据从病例记录文件中检索。从瑞典医疗出生登记处收集了潜在混杂因素的信息。计算了出生体重(BW)、出生长度(BL)和头围(HC)的标准差评分(SDS),并将其视为结果。
ACS 开始时的 GA 不影响结果。暴露于 2 个疗程的婴儿的 BW-SDS、BL-SDS 和 HC-SDS 分别为-0.21、-0.19 和+0.25,而暴露于≥4 个疗程的婴儿分别为-1.01、-1.04 和-0.23(p=0.04-0.07)。在多变量回归分析中,与暴露于 2-3 个疗程的 SDS 相比,≥4 个疗程与 BW-SDS、BL-SDS 和 HC-SDS 降低相关(p=0.007-0.04)。≥4 个疗程对 BW 和 BL 的影响与双胞胎出生时的体重和身长减小相当,对 HC 的影响与母亲吸烟后的 HC 减小相当。
多次 ACS 疗程与胎儿生长的剂量依赖性下降有关,这可能会影响后期的发育和健康。